🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi’an
Clinical trial register · China

Clinical Trials in Xi’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Xi’an

504 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study of ESG406 in Adults With Solid Tumors
NCT06979674Locally Advanced/Metastatic Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd
Phase 1
556
Chongqing, Xi’an, Hangzhou
2025-06-04
Recruiting
PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery
NCT06952387Hypotension
Nanfang Hospital, Southern Medical University
Not applicable
1,624
Guangzhou, Shenzhen, Zhuhai, Xi’an, Hangzhou
2025-06-03
Recruiting
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117Heart Valve Disease, Mitral Valve (MV) Regurgitation, Mitral Valve Disease, Mitral Valve Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Fuzhou, Wuhan, Changsha, Shenyang, Xi'an, Qingdao, Chengdu, Ürümqi
2025-06-01
By invitation
Exploration and Establishment of an Early Warning System for Futile Reperfusion - A I S
NCT07045987Acute Ischemic Stroke (AIS), Endovascular Thrombectomy, Neurovascular Unit- Brain Lymphatic System
Xijing Hospital
Observational
2,000
Xi’an
2025-06-01
Recruiting
Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).
NCT07503730APL
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
224
Xi'an
2025-06-01
Recruiting
Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy
NCT06924489Colorectal Adenoma, Colorectal Polyps
Xijing Hospital of Digestive Diseases
Not applicable
1,566
Xi'an
2025-06-01
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
NCT06979869Esophageal Cancer
Xijing Hospital
Observational
300
Wuwei, Shantou, Zhaoqing, Zhengzhou, Xi'an, Yan’an, Taiyuan, Chengdu
2025-05-26
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
NCT06979895Gastric (Stomach) Cancer
Xijing Hospital
Observational
150
Xi'an
2025-05-26
Recruiting
A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
NCT06943677Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Nanjing, Nanchang, Xi'an, Heze, Jinan
2025-05-26
Not yet open
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Intestinal Carcinoma
NCT06979882Intestinal Cancer
Xijing Hospital
Observational
200
Xi'an
2025-05-25
Recruiting
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
NCT06702553Nitric Oxide, Cardiac Surgery, Cardiopulmonary Bypass, Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary Bypass
Xijing Hospital
Phase 3
3,650
Xi'an
2025-05-19
Recruiting
Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.
NCT07092423Traumatic Brain Injury, Neurocritical Care, Enteral Feeding Intolerance
Tang-Du Hospital
Not applicable
100
Xi'an
2025-05-18
Recruiting
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients
NCT07266467Kidney Transplant
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
290
Xi'an
2025-05-13
Recruiting
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
NCT06929299Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd.
Phase 1/2
56
Bengbu, Beijing, Tangshan, Zhengzhou, Nanchang, Xi’an, Tianjin
2025-05-12
Recruiting
3D-printed Biodegradable Breast Implants for Breast Restoration
NCT06993714Breast Cancer, Breast Reconstruction
Xijing Hospital
Phase 2
120
Xi'an
2025-05-01
Active, closed
The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06958939Myasthenia Gravis, Generalized
Ting Chang, MD
Phase 1
10
Xi'an
2025-05-01
Recruiting
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
NCT07586904Melanoma (Skin Cancer)
Xijing Hospital
Phase EARLY_PHASE1
10
Xi'an
2025-05-01
Not yet open
Clinical Trial on the Efficacy and Safety of Biodegradable 3D-Printed Implants in Chest Wall Reconstruction Surgery
NCT06977022Chest Wall Tumor
Tang-Du Hospital
Not applicable
20
Xi'an
2025-05
Active, closed
Clinical Outcomes of PIMSRA Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study
NCT07003945Hypertrophic Obstructive Cardiomyopathy (HOCM)
Xijing Hospital
Observational
800
Xi'an
2025-04-29
Recruiting
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499AORTIC VALVE DISEASES, Bicuspid Aortic Valve (BAV)
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
NCT06827236Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer
BioNTech SE
Phase 1/2
380
Bengbu, Changchun, Chengdu, Chongqing, Huizhou, Nanning, Shanghai, Xi'an
2025-04-23
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
National University of Singapore
Phase 4
600
Hangzhou, Xi'an, Xuzhou
2025-04-21
By invitation
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196Psoriasis (PsO), Randomised Controlled Trial
Xijing Hospital
Phase 3
160
Xi'an
2025-04-20
Active, closed
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.
Phase 3
108
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Shenyang, Xi’an, Chengdu
2025-04-15
Recruiting
Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness
NCT06851156Disorders of Consciousness, Severe Brain Injury, Unresponsive Wakefulness Syndrome, Minimally Conscious State
Xijing Hospital
Not applicable
10
Xi'an
2025-04-07
Recruiting
Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT
NCT06900777Vitiligo, Child, Progressive Disease
Xijing Hospital
Not applicable
90
Xi'an
2025-04-01
Recruiting
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
NCT07068607Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
Yongquan Shi
Phase 4
400
Xi'an
2025-04-01
Not yet open
Hypotension Prediction Index and Intraoperative Hypotension Incidence
NCT06909786Intraoperative Hypotension
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2025-04-01
Not yet open
A Study on the Safety and Functionality of the Implantable Wireless Brain-Computer Interfaces for Motor Rehabilitation
NCT06944834Quadriplegia, Amputations, Spinal Cord Injuries (SCI), Brainstem Stroke
Shanghai StairMed Technology Co., Ltd.
Not applicable
5
Xi'an
2025-04
Not yet open
Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE
NCT06832813Drug-resistant Epilepsy, Transcranial Magnetic Stimulation
Xijing Hospital
Not applicable
100
Xi'an
2025-03-28
Not yet open
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
NCT06914427Prostatic Neoplasms, Glioma, PARKINSON DISEASE (Disorder)
Xijing Hospital
Not applicable
35
Xi'an
2025-03-28
By invitation
Project on tDCS Intervention to Enhance Advanced Social Cognitive Functions in Drug Rehabilitation Individuals
NCT06888700Drug Addiction
Shaanxi Normal University
Not applicable
84
Xi'an
2025-03-19
Active, closed
The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer
NCT07252297Non-muscle Invasive Bladder Cancer
Xijing Hospital
Not applicable
177
Xi'an
2025-03-18
Recruiting
The Effect of VitC on IVF Outcome of DOR Patients
NCT06794047Diminished Ovarian Reserve, IVF Outcomes
Peking University Third Hospital
Not applicable
1,100
Beijing, Shijiazhuang, Yinchuan, Xi’an, Shenzhen
2025-03-17
Active, closed
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
NCT07104201Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases
Phase EARLY_PHASE1
15
Xi'an
2025-03-13
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466Menstrual Migraine
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Active, closed
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
NCT06876636Breast Cancer Metastatic
Xijing Hospital
Not applicable
99
Xi'an
2025-03-10
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
Alexion Pharmaceuticals, Inc.
Phase 2
47
Changsha, Guangzhou, Nanning, Shanghai, Wuhan, Xi'an
2025-03-07
Recruiting
The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF
NCT06742788Infertility Assisted Reproductive Technology
Xijing Hospital
Not applicable
90
Xi'an
2025-03-04
Recruiting
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
NCT07050537Fertility Issues, Blastocyst IVF, Embryo Culture
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xi’an
2025-03-01
Not yet open
Precision Transcranial Magnetic Stimulation for Depression Based on Orbital Frontal Cortex-habenula Circuitry
NCT06837207Depression, Transcranial Magnetic Stimulation
Xijing Hospital
Not applicable
30
Xi'an
2025-03-01
Recruiting
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
NCT06610266Gastric Intestinal Metaplasia
Yongquan Shi
Phase 4
400
Ankang, Tongchuan, Weinan, Xi'an, Xuchang, Yanan
2025-02-28
By invitation
Coronary Arterial Microcirculation and Metabolism
NCT07074847Coronary Atherosclerosis of Native Coronary Artery
Shaanxi Provincial People's Hospital
Observational
100
Xi'an
2025-02-28
Recruiting
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
NCT06873659Solid Tumor, Gastric Cancer, Liver Cancer
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
NCT06896747Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions
Tang-Du Hospital
Phase 1/2
90
Xi'an
2025-02-21
Not yet open
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention, High Risk Patient
Xijing Hospital
Not applicable
12,000
Xi'an
2025-02-20
Recruiting
Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness
NCT06914583Facial Dryness, Facial Dullness
IBSA Farmaceutici Italia Srl
Not applicable
500
Beijing, Changde, Chengdu, Shanghai, Xi'an
2025-02-19
Recruiting
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
NCT06864624NSCLC
Tang-Du Hospital
Phase 2
27
Changsha, Yinchuan, Xi'an
2025-02-18
Active, closed
PET/MRI Artificial Intelligence Reconstruction Algorithm AIR Recon DL Image Quality Evaluation and Clinical Study
NCT06856096Parkinson's Syndrome
Xijing Hospital
Not applicable
65
Xi'an
2025-02-10
Active, closed
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293Menstrual Migraine (MM)
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Active, closed
68Ga-Pentikra PET/CT Imaging Study in Healthy Subjects
NCT06856109Healthy Volunteers
Xijing Hospital
Not applicable
10
Xi'an
2025-02-10
Active, closed
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236Platinum-resistant Ovarian Cancer
Genmab
Phase 3
530
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome
NCT06722534Peutz-Jeghers Syndrome, Celecoxib, Small Bowel Polyp
Air Force Military Medical University, China
Not applicable
80
Xi'an
2025-02-01
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
Not yet open
Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures
NCT06762704The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,408
Hefei, Nanjing, Nanchang, Xi'an, Shanghai
2025-02
By invitation
Randomized Controlled Study on the Safety and Efficacy of Phage Cocktail in the Treatment of Multidrug-Resistant Bacterial Skin Infections
NCT07619924Phage Therapy, Bacteriophage Therapy, Skin and Soft Tissue Infections
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1
150
Xi'an
2025-01-15
Not yet open
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273Arrhythmia, Acute Cerebrovascular Disease
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2025-01-15
Not yet open
Abdominal Transcutaneous Electrical Acupoint Stimulation on Children With Autism Spectrum Disorder
NCT06763237Autism Spectrum Disorder, Autism in Children
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
42
Xi'an
2025-01-10
Recruiting
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)
NCT06669182Alzheimer Disease, Transcranial Magnetic Stimulation, Cerebellum
Xijing Hospital
Not applicable
100
Xi'an
2025-01-07
Recruiting
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
NCT06995170Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease, Polyamines
Xijing Hospital
Observational
146
Xi'an
2025-01-01
Recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
NCT06613165Immune-related Adverse Event, Neoadjuvant Therapy, dMMR Colorectal Cancer
Xijing Hospital
Observational
100
Xi'an
2025-01-01
Recruiting
A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
NCT06791005Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University
Phase 3
400
Xi'an
2025-01-01
Recruiting
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
NCT07079150Hepatitis B, Chronic (CHB), Hepatitis B, Hepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2025-01-01
Not yet open
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
NCT05965375Ventricular Arrythmia
First Affiliated Hospital Xi'an Jiaotong University
Observational
5,000
Xi'an
2024-12-31
Not yet open
Response of Intracardiac Thrombus to Anticoagulants in Patients With Non-valvular Atrial Fibrillation (LYSIS)
NCT06141538Atrial Fibrillation, Intracardiac Thrombus
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-12-31
Not yet open
Deep Learning for Intelligent Identification of Arrhythmias
NCT05967546Arrhythmia
First Affiliated Hospital Xi'an Jiaotong University
Observational
4,000
Xi'an
2024-12-30
Recruiting
A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation
NCT06756490Moderate or Severe Submental Fullness
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
30
Beijing, Xi'an
2024-12-26
Recruiting
Risk Factors for Complications After Cranioplasty
NCT06740773Cranioplasty, Postoperative Complications, Risk Assessment
Qilu Hospital of Shandong University
Observational
1,000
Chongqing, Xi'an, Jinan
2024-12-17
Recruiting
Clinical Trial of TQB3002 in Patients With Advanced Cancers
NCT06662760Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
150
Guangzhou, Shenzhen, Zhengzhou, Nanjing, Nanchang, Shanghai, Xi’an, Chengdu
2024-12-09
Not yet open
MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding
NCT06698874Gastrointestinal Bleeding, Antiplatelet Therapy
Changhai Hospital
Not applicable
204
Qinghai, Shanghai, Xi'an
2024-12-01
Recruiting
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
NCT06717412Retinopathy of Prematurity (ROP)
Wang Yusheng
Not applicable
146
Xi'an, Xianyang
2024-11-29
Recruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06684106Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
128
Xi'an
2024-11-25
Active, closed
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
NCT06576921Stomach Neoplasms, Immune Checkpoint Inhibitors
Xijing Hospital
Phase 2
116
Shijiazhuang, Xi'an, Tianjin
2024-11-15
Active, closed
A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China
NCT06548568Diabetic Macular Edema
AbbVie
Observational
110
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Dalian, Xi'an, Qingdao
2024-11-13
Recruiting
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
NCT06610760Gastric Intestinal Metaplasia
Yongquan Shi
Phase 4
196
Pingdingshan, Ankang, Hanzhong, Shangluo, Xi'an
2024-11-12
Active, closed
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
NCT06523764Helicobacter Pylori Infection Chronic Gastrit
Xijing Hospital of Digestive Diseases
Phase 4
208
Xi'an
2024-11-11
Recruiting
Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
NCT06756139Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug
Air Force Military Medical University, China
Not applicable
88
Haikou, Xi'an, Mianyang
2024-11-01
Active, closed
Efficacy and Safety Evaluation of Microfocused Ultrasound Combined With 1550 nm Non-Ablative Fractional Laser for Facial Rejuvenation
NCT07107308Photo-aged Skin
Second Affiliated Hospital of Xi'an Jiaotong University
Not applicable
25
Xi’an
2024-11-01
Not yet open
Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging
NCT06681155Coronary Arterial Disease (CAD), Acute Coronary Syndromes
Chinese PLA General Hospital
Observational
500
Shenzhen, Wuhan, Changchun, Xi'an, Ürümqi, Hangzhou, Beijing
2024-11
Not yet open
Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN)
NCT06504056Isolated Noncompaction of the Ventricular Myocardium
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-10-30
Recruiting
Rapid dFLC Response Predict CHR in AL Amyloidosis
NCT06627309Systemic AL Amyloidosis
Peking University People's Hospital
Observational
50
Beijing, Harbin, Nanjing, Shenyang, Xi'an
2024-10-26
Recruiting
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
NCT06644118Multiple Myeloma
Zhejiang University
Phase 1
58
Beijing, Xi’an, Hangzhou
2024-10-23
Active, closed
Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation
NCT06780930Residual or Recurrent Grade 2 IDH Mutant Glioma
Servier
Phase 3
57
Shenzhen, Chengdu, Beijing, Shanghai, Xi'an
2024-10-18
Recruiting
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
NCT06770478Tumour of Epithelial Origin, 68Ga-MY6349
Xijing Hospital
Not applicable
40
Xi'an
2024-10-18
Recruiting
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
NCT06572267Coronary Artery Disease
Xijing Hospital
Phase 2
18
Xi'an
2024-10-16
Not yet open
Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery
NCT06607081Degenerative Spinal Disease, Elderly Patients, Spinal Fusion Acquired
Xijing Hospital
Not applicable
5,000
Xi'an
2024-10-15
Recruiting
Short-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial
NCT07087561Colorectal Cancer (Diagnosis), Malnutrition or Risk of Malnutrition
Xiaoqin Luo
Not applicable
360
Xi'an
2024-10-10
Recruiting
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
NCT07139509Relapsed/Refractory Multiple Myeloma(MM)
Xi'an No.3 Hospital
Phase 1
18
Xi’an
2024-10-03
Recruiting
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
NCT07180368Coronary Artery Disease, Diabete Mellitus, Chronic Kidney Disease, Hypertension
Xijing Hospital
Observational
2,000
Xi'an
2024-10-01
Recruiting
Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
NCT06663059Esophageal Cancer
Tang-Du Hospital
Phase 2
80
Xi'an
2024-10-01
Recruiting
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
NCT06617182Radiation Enteritis
Yongquan Shi
Phase 2
150
Xi'an
2024-09-30
By invitation
The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD
NCT07257588Ulcerative Colitis
Xijing Hospital of Digestive Diseases
Not applicable
44
Xi'an
2024-09-30
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Xi'an, Shanghai
2024-09-26
Recruiting
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
NCT06609447Ulcerative Colitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
100
Beijing, Chongqing, Guangzhou, Wuhan, Xi’an, Chengdu, Hangzhou, Huzhou
2024-09-21
Recruiting
Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer
NCT06492785Infertility
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
858
Xi'an
2024-09-13
Recruiting
Efficacy and Mechanism of rTMS on the Symptoms of Pleasure Deficit in Adolescent Depression
NCT06580249Depression
Xijing Hospital
Not applicable
44
Xi'an
2024-09-05
Rows per page Showing 201–300 of 504
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 504 of those studies with a site in Xi’an.

How many clinical trials are recruiting in Xi’an?

314 of the 504 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 94 have not yet opened recruitment, 77 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.